Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Hemoglobin. 2020 Jul;44(4):225-230. doi: 10.1080/03630269.2020.1790384. Epub 2020 Jul 16.
β-Thalassemia (β-thal) is one of the most frequent genetic disorder in Iran with great mutational diversity. In this study, we describe two novel and five rare mutations in the non coding regions of the β-globin gene; these mutations were identified in the non coding regions of the β-globin gene () in the heterozygous state. Three alterations were detected in the promoter region, including -9 (C>G) [: c.59C>G (novel mutation)], -54 (G>A) (: c.-104G>A) and -57 (A>T) (: c.-107A>T), three changes in the 5' untranslated region (5'UTR) including +11 (C>G) [: c.-40C>G (novel mutation)], +41 (A>T) (: c.-10A>T) and +43 (C>G) (: c.-8C>G) and one mutation in the 3'UTR 62 (A>G) (: c.*62A>G). Five mutations including -54, -57, +41, +11 and +43 were predicted to be deleterious in all except one prediction tool, and the remaining two mutations were found to be most likely polymorphisms. In conclusion, two novel mutations were reported for the first time worldwide and five rare changes have not been reported previously in any other part of Iran. In the absence of further data, it is not possible to consider them as mutations that determine an ascertained healthy carrier state.
β-地中海贫血(β-thal)是伊朗最常见的遗传疾病之一,具有很大的突变多样性。在这项研究中,我们描述了β-珠蛋白基因非编码区的两个新突变和五个罕见突变;这些突变是在β-珠蛋白基因的非编码区()中以杂合状态发现的。在启动子区域检测到三个改变,包括-9(C>G)[:c.59C>G(新突变)]、-54(G>A)[:c.-104G>A]和-57(A>T)[:c.-107A>T],在 5'非翻译区(5'UTR)中检测到三个改变,包括+11(C>G)[:c.-40C>G(新突变)]、+41(A>T)[:c.-10A>T]和+43(C>G)[:c.-8C>G],在 3'UTR 中检测到一个突变 62(A>G)[:c.*62A>G]。除了一个预测工具外,所有其他预测工具都预测-54、-57、+41、+11 和+43 这五个突变是有害的,其余两个突变被发现最有可能是多态性。总之,这两个新突变是全球首次报道的,而这五个罕见的变化在伊朗的其他任何地区都没有被报道过。在没有进一步数据的情况下,不可能将它们视为确定健康携带者状态的突变。